Yoshida H

No ORCID on file · 28 papers in corpus · active 1968-2026

Study types

  • article 10
  • case-report 2
  • other 2
  • rct 1
  • review 1

Condition tags

  • endometriosis 14
  • infertility 4
  • thoracic_endometriosis 1
  • adenomyosis 1
2026
Reproductive medicine and biology ·doi:10.1002/rmb2.70032

PurposeTo estimate the prevalence and correlates of low serum 25-hydroxyvitamin D [25(OH)D] among women attending infertility clinics in Japan.MethodsWe conducted a multicenter cross-sectional study of 17 261 women with measured 25(OH)D. De…

2025
Human cell ·doi:10.1007/s13577-025-01176-0

Only a few human ovarian endometrioid carcinoma cell lines are currently available, partly due to the difficulty of establishing cell lines from low-grade cancers. Here, using a cell immortalization strategy consisting of i) inactivation of…

article 2025
Oncology research ·doi:10.32604/or.2025.068432

Ovarian endometrioid carcinoma (OEC) accounts for ~10% of epithelial ovarian cancers and displays broad morphologic diversity that complicates diagnosis and grading. Recent data show that the endometrial cancer molecular taxonomy (DNA polym…

2025
Reproductive medicine and biology ·doi:10.1002/rmb2.12634

PurposeTo evaluate the impact of Endometrial Microbiome Metagenomic Analysis and Analysis of Infectious Chronic Endometritis (EMMA & ALICE) on pregnancy outcomes following recommended treatments in women with recurrent implantation failure …

2024
Scientific reports ·doi:10.1038/s41598-024-70228-6

Epithelial ovarian cancer (EOC) is widely recognized as the most lethal gynecological malignancy; however, its early-stage detection remains a considerable clinical challenge. To address this, we have introduced a new method, named Comprehe…

2024
Human cell ·doi:10.1007/s13577-024-01058-x

A human ovarian clear cell carcinoma cell line was established from a 46-year-old Japanese woman. That line, designated MTC-22, has proliferated continuously for over 6 months in conventional RPMI 1640 medium supplemented with 10% foetal bo…

2023
Reproductive medicine and biology ·doi:10.1002/rmb2.12550

PurposeTo evaluate clinical outcomes after endometrial receptivity analysis (ERA).MethodsThis was a multicenter, retrospective cohort study involving 861 women who underwent ERA testing at certified fertility clinics in Japan, and who recei…

2023
Nutrients ·doi:10.3390/nu15173730

Homocysteine is an amino acid naturally produced in the body and metabolized via the methionine cycle. High homocysteine levels can increase the risk of infertility and pregnancy complications, such as preeclampsia, preterm delivery, miscar…

2023
Medicina (Kaunas, Lithuania) ·doi:10.3390/medicina59101715

Background and Objectives: Vasa previa (VP) is a significant perinatal complication that can have serious consequences for the fetus/neonate. Velamentous cord insertion (VCI) is a crucial finding in prenatal placental morphology surveillanc…

2022
Reproductive medicine and biology ·doi:10.1002/rmb2.12459

PurposeOur aim is to make an ideal embryo culture medium close to human oviduct fluid (HOF) components, and to evaluate the quality of this medium with embryo quality and clinical outcomes in assisted reproductive technology (ART) by a pros…

other 2021
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2020.12.042

OBJECTIVE: To examine the safety and feasibility of total laparoscopic retrograde hysterectomy (TLreH) in patients with obliterated cul-de-sac due to severe endometriosis. STUDY DESIGN: This retrospective case-control observational study w…

case-report 2021
Gynecologic oncology reports ·doi:10.1016/j.gore.2020.100692

•A 56-year-old woman developed two seromucinous borderline tumors 26 years apart.•The second cyst was diagnosed as a seromucinous borderline tumor associated with pelvic endometriosis.•The first ovarian cancer was re-diagnosed as an ovarian…

2020
Oncology letters ·doi:10.3892/ol.2020.11899

Patients with cervical adenocarcinoma (AC) and adenosquamous carcinoma (ASC) have a poorer prognosis than those with squamous cell carcinoma (SCC). Erb-b2 receptor tyrosine kinase 3 (HER3) is a member of the epidermal growth factor receptor…

article 2019
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.14181

Endometriosis-related cervical neoplasms are rare, and their clinicopathological features and association with human papilloma virus infection are unclear. A postmenopausal woman with recently diagnosed cervical adenocarcinoma was referred …

rct 2019
Journal of ovarian research ·doi:10.1186/s13048-019-0597-y

BACKGROUND: Endometriosis is considered to be the most intractable cause of female infertility. Administering any type of treatment for endometriosis before in vitro fertilization and embryo transfer (IVF-ET) is an important strategy for im…

2018
Gynecology and Minimally Invasive Therapy ·doi:10.4103/gmit.gmit_57_18

Study objectivesThe aim of this study is to evaluate the effects of vaginal estriol therapy in total laparoscopic hysterectomy (TLH) with gonadotropin-releasing hormone agonist (GnRH-a) treatment.DesignRetrospective analysis.Design classifi…

article 2018
Gynecologic oncology reports ·doi:10.1016/j.gore.2018.12.007

A solitary pelvic tumor after treating a primary endometriosis-related neoplasm is usually considered a recurrence but may actually be a primary endometriosis-related peritoneal neoplasm. A Japanese woman in her late 60s was referred to our…

2018
The journal of obstetrics and gynaecology research ·doi:10.1111/jog.13675

AimTo investigate the differences in leiomyoma pathophysiology by patient age at the time of surgery and the possible significance of postmenopausal uterine leiomyomas, particularly variants.MethodsWe retrospectively reviewed data from 471 …

article 2013
Reproductive medicine and biology ·doi:10.1007/s12522-013-0146-0

) levels suggest the presence of potential follicles. The EFS is a rare condition with an incidence of 0.5-7 % of women undergoing IVF treatments. Although there are many hypotheses as to the cause of EFS, including advanced ovarian age, dr…

case-report 2008
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2008.02.012

We report a rare case in which a cystic lesion in the cervix, caused by endometriosis, resulted in a massive vaginal hemorrhage. Cervical endometriosis is relatively common and is usually considered a mild condition. However, we report a ca…

article 2004
Reproductive medicine and biology ·doi:10.1111/j.1447-0578.2004.00050.x

Background : Decreased conception rate with advanced maternal age has been well demonstrated. Although this decline becomes apparent at 35 years of age, and accelerates rapidly in women over 40 years of age, we are able to report pregnancy …

article 2001
Oncology reports ·doi:10.3892/or.8.6.1317

The expression of vascular endothelial growth factor (VEGF) and cyclooxygenase-2 (COX-2) were immunohistochemically examined in both pelvic and extrapelvic endometriotic lesions. Different expressions of VEGF and COX-2 were observed in both…

article 1999
Kyobu geka. The Japanese journal of thoracic surgery

A 30-year-old female had twice experienced right pneumothorax within 2 months that was related to the onset of menstruation, suggesting catamenial pneumothorax. Right thoracoscopy revealed the presence of "blue berry spots" and pinhole at t…

review 1999
Gynecologic and obstetric investigation ·doi:10.1159/000052854

Defects in the cell-mediated immune system may play a role in the pathogenesis or progression of pelvic endometriosis. Possible mediators include macrophages, interleukins-1 and -6, and tumor necrosis factor-alpha. More recent work points t…

article 1997
Fertility and Sterility ·doi:10.1016/s0015-0282(97)00226-4

ObjectiveWe evaluated the secretion of hepatocyte growth factor by eutopic endometrial stromal cells in vitro.DesignEutopic endometrial stromal cells were isolated and the culture supernatants were collected after 48 hours of incubation. Th…